胸部主動脈覆膜支架市場:開發平台(管線)報告(開發階段,市場區隔,地區·國家,法規途徑,主要企業),2024最新版
市場調查報告書
商品編碼
1617532

胸部主動脈覆膜支架市場:開發平台(管線)報告(開發階段,市場區隔,地區·國家,法規途徑,主要企業),2024最新版

Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 56 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

胸主動脈覆膜支架用於透過微創手術加強部分主動脈來治療胸主動脈瘤。

本報告提供胸部主動脈覆膜支架pu市場相關調查,產品概要與正在開發的開發中產品趨勢,各種各樣的處於開發階段的產品的比較分析和進行中的臨床試驗相關資訊,參與企業的最近趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

  • 胸部主動脈覆膜支架概要

第3章 開發中的產品

  • 胸部主動脈覆膜支架 - 各開發階段平台產品
  • 胸部主動脈覆膜支架 - 各地區開發中產品
  • 胸部主動脈覆膜支架 - 各法規途徑開發中產品
  • 胸部主動脈覆膜支架 - 估計核准日開發中產品
  • 胸部主動脈覆膜支架 - 進行中的臨床試驗

第4章 胸部主動脈覆膜支架- 各公司正在開發的開發中產品

  • 胸部主動脈覆膜支架企業-各開發階段的開發中產品
  • 胸部主動脈覆膜支架-各開發階段的開發中產品

第5章 胸部主動脈覆膜支架企業與產品概要

第6章 胸部主動脈覆膜支架-最近的趨勢

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
Product Code: GDME1891EPD

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Thoracic Aortic Stent Grafts Overview

3 Products under Development

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Thoracic Aortic Stent Grafts Companies and Product Overview

6 Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
  • 6.2 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
  • 6.3 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
  • 6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.6 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
  • 6.7 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
  • 6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs
  • 6.9 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
  • Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials